Velan Capital Investment Management LP 13D/13G Filings for Jasper Therapeutics, Inc. (JSPR)

Velan Capital Investment Management LP 13D and 13G filings for Jasper Therapeutics, Inc.:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime
Transaction
Date
TypeCompany
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev ReportView
2023-02-27
4:05 pm
Unchanged
2023-02-1613DJasper Therapeutics, Inc.
JSPR
Velan Capital Investment Management LP1,121,904
10.200%
0
(Unchanged)
Filing
2023-01-27
4:56 pm
Purchase
2023-01-2513GJasper Therapeutics, Inc.
JSPR
Velan Capital Investment Management LP1,121,904
10.200%
1,121,904increase
(New Position)
Filing